Even plans that include a weight loss indication typically require prior authorization, a BMI threshold, and documentation of previous weight loss attempts
Included studies provided evidence for a heterogenous population of patients with T2DM in terms of disease background, treatment experience, background therapies, and comorbid conditions (renal impairment and CV disease)
The hypothalamic-pituitary-ovarian axis is particularly sensitive to energy availability and metabolic status
In expansion, it contributes to the resistance framework execution by keeping up the wellbeing of resistant cells
Current prescribing information includes warnings related to elevated IGF-1, glucose intolerance, fluid retention, malignancy risk, hypersensitivity, and injection-site reactions. A complete safety discussion belongs in a separate article, but these limitations are essential when interpreting potential benefits